Sep 18, 2026 04:47PM
Sep 18, 2026 04:45PM
Sep 9, 2026 04:30PM
Jul 7, 2026 04:23AM
Jul 6, 2026 06:20PM
Jun 30, 2026 04:40PM
Jun 4, 2026 05:02PM InMed Pharmaceuticals regains nasdaq listing compliance
Jun 4, 2026 05:00PM
May 19, 2026 08:06AM
May 19, 2026 06:08AM
May 19, 2026 06:00AM
May 6, 2026 06:00PM
Apr 27, 2026 05:30PM
Mar 27, 2026 05:06PM InMed Pharmaceuticals gets Nasdaq notice on minimum bid price
Mar 27, 2026 05:05PM
Mar 23, 2026 07:32AM
Mar 23, 2026 07:30AM
Mar 9, 2026 07:30AM
Mar 6, 2026 05:04PM
Feb 11, 2026 05:23PM
Dec 17, 2025 08:00PM InMed Announces Results of 2025 Annual General and Special Meeting
Dec 12, 2025 05:31PM
Nov 18, 2025 07:32AM
Nov 18, 2025 07:30AM
Nov 6, 2025 04:51PM
Oct 16, 2025 08:32AM
Oct 16, 2025 08:30AM
Oct 14, 2025 06:07AM InMed Pharmaceuticals appoints Neil Klompas to board of directors
Oct 9, 2025 08:32AM
Oct 9, 2025 08:30AM
Sep 23, 2025 08:30AM
Sep 5, 2025 09:33AM
Aug 1, 2025 06:05AM
Jul 28, 2025 07:00AM
Jun 27, 2025 07:00AM InMed Pharmaceuticals Announces Closing of $5 Million Private Placement Priced At-the-Market under Nasdaq Rules
Jun 25, 2025 08:03AM
Jun 25, 2025 08:00AM
Jun 24, 2025 07:02AM
Jun 24, 2025 07:00AM
Jun 13, 2025 04:30PM
May 13, 2025 06:46AM
May 12, 2025 06:00PM InMed Reports Third Quarter Fiscal 2025 Financial Results and Provides Business Update
Feb 13, 2025 04:08AM
Feb 13, 2025 04:05AM
Feb 12, 2025 06:54PM
Feb 3, 2025 07:33AM
Feb 3, 2025 07:30AM
Jan 22, 2025 07:32AM
Jan 22, 2025 07:30AM InMed Pharmaceuticals Announces Granting of Patent for Novel Compounds
Jan 21, 2025 07:34AM

470,302 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All